355 results about "Medicine" patented technology

A gas sampling line having a channel for conducting respiratory gases from a patient respiratory interface to a gas monitor, the gas sampling line comprising, i.a., a gas sampling tube comprised of a polyether block amide material, the polyether segments of which comprise polyethyleneoxide. Use of a tube comprised of a polyether block amide material, the polyether segments of which comprise polyethyleneoxide, for sampling of respiratory gases; and a method for sampling of respiratory gases, the method comprising conducting respiratory gases through such a tube. A gas analysis system for analysing respiratory gases, comprising a gas sampling line as defined above and a gas monitor connectable to the gas sampling line.

A method and device to modify tissue in a manner such that it will take on a permanent new shape. Subdermal tissue is heated to approx 60° C. at which point it becomes pliable and moldable and will take on a permanent new shape if allowed to cool and heal in a new position.

Provided is a novel modular tibial prosthesis that includes an articulation component formed by direct pressure molding of a resin composition into a tibial tray component to provide a factory formed resin-metal composite structure a tibial tray module. The tibial tray component being capable of releasable attachment to an underlying keel element. A method of manufacture of the tibial prosthesis is also disclosed.

A system and method for the treatment of a skin comprising. The system comprises an applicator having a cavity and one or more light sources configured to irradiate the cavity with optical energy simultaneously from at least two directions. The applicator is applied to the skin and a region of skin is made to protrude into the cavity. The protruding region of skin is then irradiated with optical energy from the one or more light sources simultaneously from at least two directions.

The invention discloses a serum specificity metabolite spectrum for a patient with a lung cancer and a building method thereof, and particularly discloses a method for carrying out liquid-phase/gas-phase chromatography mass spectrometry metabonomics analysis based on the patient suffering from the lung cancer. The method comprises the following steps: collecting fasting blood samples of a healthy and normal detected person and the patient suffering from the lung cancer 7 days before and after an operation, separating by a chromatogram column after processing; extracting and aligning original data of an instrument after adopting mass spectrometry analysis; building a mathematical model to analyze the metabolites spectrum by adopting multivariable data statistical software; comparing with the difference between an average person with the metabolites spectrum of the patient with the lung cancer, so as to determine the specificity metabolite spectrum. By adopting the method disclosed by the invention, the mutation status of the metabolite of the patient with the lung cancer can be generally and comprehensively reflected, and the serum specificity metabolite spectrum can be applied to early diagnosis of the lung cancer or a beneficial technical support is supplied for prognosis.

The present invention embodies delivery systems and methods for delivering medical repair devices that allow the flexibility of the delivery system to be varied and allow the delivery system to be steered and directed in a particular direction.

The invention discloses a skin-whitening cosmetic and a preparation method thereof and aims to provide a skin-whitening cosmetic which is excellent in whitening performance, free of lead and other ingredients harmful to the human bodyand high in safety. The skin-whitening cosmetic is characterized by being prepared from the following components in percentage by weight: 12-18% of moisturizing agent, 0.4-0.8% of preservative, 0.4-0.8% of freckle removing agent, 0.3-0.7% of solubilizer, 0.1-0.5% of thickening agent, 1.0-1.6% of skin conditioner, 0.5-1.5% of skin-whitening agent, 0.1-0.5% of chelating agent, 0.1-0.5% of antioxidant, 0.1-0.5% of aromatic and the balance of water. The skin-whitening cosmetic belongs to the technical field of the cosmetics.

A patient immobilization device for immobilizing a patient and performing a diagnostic evaluation of such patient is comprised of a backboard, a structure configured to support the head of a patient on the backboard, and a pupil-sizing indicator positioned on a surface of the support structure to be visually accessible to a person that is visually evaluating the head and face of an immobilized patient on the backboard.

The invention relates to a method of treatment of resistance to platelet inhibitors, i.e. a method to overcome resistance of treatment with platelet inhibitors, said method comprising administering a therapeutically effective amount of dipyridamole in combination with a platelet inhibitor and, optionally, in combination with a third antithrombotic component such as direct thrombin inhibitors, factor Xa inhibitors, combined thrombin/factor Xa inhibitors, heparin, low molecular weight heparin, argatroban, bivalrudin, hirulog or polyglycans to a patient in need thereof. The invention further relates to the use of dipyridamole for the manufacture of a pharmaceutical composition for treatment of resistance to platelet inhibitors. The invention also relates to a method to diagnose resistance to treatment with platelet inhibitors, said method comprising measurement of the density of binding of Annexin V on platelets.

A heart valve prosthesis includes a valve member having an inflow end, an outflow end, and a generally cylindrical sidewall portion extending between the inflow end and the outflow end. The valve member includes at least one leaflet moveable relative to the sidewall portion to provide for substantially unidirectional flow of fluid through the valve member. A support of a substantially flexible material positioned is around the sidewall portion. A strip of pliant material is provided around valve member intermediate the inflow end and the outflow end of the valve member in a generally overlying relationship with the support. A covering is provided over a radially outer exposed surface of at least the strip.

The present invention provides methods, compositions, and kits for the treatment of disorders associated with overactivation of FGFR3, such as achondroplasia; bone or cartilage disorders; or vascular smooth muscle disorders, or for the elongation of bone. In some embodiments, the present invention provides polypeptides having a natriuretic peptide fused to an Fc domain of an immunoglobulin. Such polypeptides can be administered to subjects, e.g., subcutaneously, to treat a disorder associated with overactivation of FGFR3, a bone or cartilage disorder, or a vascular smooth muscle disorder, or to elongate bone. The invention also features nucleic acid molecules encoding such polypeptides and the use of the nucleic acid molecules for treating disorders associated with overactivation of FGFR3, bone or cartilage disorders, or vascular smooth muscle disorders, or for elongating bone.

A health-care food in the form of soft-capsule, capsule, particle, tablet, or oral liquid for improving immunity and preventing and treating the injury of stomach mucosa is proportionally prepared from the oil of seabuckthorn fruit and the extract of propolis through mixing and shaping.

Standard reference materials and related methods are described for quality testing and calibration of instruments used for the qualitative and quantitative determination of hemoglobin and glycated hemoglobin as well as other analytes of interest in animal tissue samples. The reference solutions of the disclosure utilize a synthetic cruor in combination with an Hb peptide chain.

It is an object of the present invention to provide a solution for creating an effective method for retarding unhealthy manifestations brought by ageing of human beings (in particular, but not limited to the reduction of sexual activity and fertility, climax, changes in glucose tolerance, reduction of cognitive and mnestic functions, reduction of stress resistance, development of organ and tissue sclerosis) without directly affecting the genetic apparatus of the ageing cells.

According to the invention this task is solved by administration into the blood circulation of the agent which inactivates extracellular blood plasma DNA; the extracellular blood DNA inactivating agent can be embodied in the form of an extracellular blood plasma DNA destroying agent; said extracellular blood plasma DNA destroying agent can be embodied in the form of an DNase enzyme; the extracellular blood plasma DNA inactivating agent can also be embodied in the form of an extracellular blood plasma DNA binding agent; the extracellular blood plasma DNA binding agent can be embodied in the form of anti-DNA antibodies; the extracellular blood plasma DNA inactivating agent can be administered in the form of an enzyme modifying the chemical composition of extracellular blood plasma DNA; the extracellular blood plasma DNA inactivating agent can be embodied in the form of an agent that stimulates synthesis or activity of endogenous deoxyribonuclease, or an agent that stimulates the synthesis of antibodies which capable to bind extracellular blood plasma DNA.

The present invention relates to a method of treating or improving rheumatism and pain caused by rheumatism, tumor, and spinal damage of mammalian animals by a non-pharmacological method. Extremely low AC electric field with DC electric field overlapped is exposed to a whole or a part of mammalian animals with electrodes in a non-contact state. In the exposure of the above mentioned electric field, said electric field is exposed for a certain period of time a day, repeating this everyday or once a week. Further, as required, frequency of the electric field, voltage to be applied, exposure time, and the like are controlled.

The invention relates to a degumming composite which comprises D-limonene, a surface active agent and a synergist. The invention also relates to a degumming aerosol containing the debugging composite, and a preparation method of the degumming aerosol. With adoption of the debugging composite provided by the invention, the potential risk due to the inflammability of turpentine can be removed, the safety in a debugging process can be improved, and the effect of debugging is ensured. The degumming aerosol provided by the invention is simple in manufacture technology, and safe and convenient to carry, store and use of the finished product and can be widely applied; compared with the current degumming agent, a great quantity of liquid solvent is saved, and the activity of the D-limonene can be protected so as to prevent the D-limonene from being oxidized via the air and the sunshine, as well as avoid losing the efficacy, and as a result, the shelf life of the product is prolonged; and moreover, the degumming composite and the degumming aerosol have the advantages of quick volatilizing, fresh air, non-residual matter, and are non-toxic to human bodies and environments.

The invention discloses a focused ultrasound-polymeric micelle controllable drug release device and a release method thereof. The device is characterized by consisting of a focused ultrasound system and a drug loaded polymeric micelle system, wherein the focused ultrasound system is connected with a focused ultrasound energy converter (3) by a signal generator (1) through a power amplifier (2); the drug loaded polymeric micelle system consists of a complex micelle (5) formed by amphiphilic block copolymers and drugs and a medium (4); and a drug loaded polymeric micelle is internally provided with a sensor (6) which is connected with a computer (8) through a signal processor (7). The focused ultrasound-polymeric micelle controllable drug release method comprises the step that the drug carried polymeric micelle is prepared through a dialysis method or a solvent evaporation method, and under ultrasonic irradiation, the polymeric micelle responds to ultrasound through a physical or chemical change so as to ensure that loaded hydrophobic drugs are released from the micelle and enter a focal part.

The invention discloses an on-line control method for a preparation process of fructus gardenia. In order to solve the technical problem of lack of objectivity caused by taking the personal experience in observation of color as a sole control method in the preparation process of the traditional Chinese medicine fructus gardenia in the prior art, the invention introduces a technique capable of accurately quantifying traditional Chinese medicine appearance and color and a method for directly measuring color of fruit peels and seed kernels of various fructus gardenia decoction pieces. The method is characterized by quantifying the color data, carrying out statistical calculation, determining a mathematic discrimination function of the fructus gardenia and applying the function to the on-line control of the preparation process of the fructus gardenia decoction pieces. When the method is applied to the on-line production of the fructus gardenia, the stability of the quality of the ructus gardenia decoction pieces can be ensured; the method has the advantages of objectivity, rapidity and reliability; the technical problem of lack of objectivity caused by artificial judgment in the prior art can be solved.

The invention relates to a drug use warning information processing method. The method is characterized by comprising the steps of 1, receiving drug use medical order information generated by a first terminal; 2, extracting drug use information and disease condition information from the drug use medical order information; 3, querying a reasonable drug use rule library by utilizing the drug use information and the disease condition information, and when the drug use information does not conform to the reasonable drug use rule library, executing the step 4; and 4, generating a drug use unreasonable rule data set according to the reasonable drug use rule library, wherein the drug use unreasonable rule data set contains a drug use unreasonableness value; and 5, generating drug use warning information, wherein the drug use unreasonableness value is marked in the drug use warning information. According to the drug use warning information processing method provided by the invention, the unreasonable drug use situation can be avoided, so that the drug use safety of patients is improved.

Fibrin-binding peptides having high binding affinity and excellent physical characteristics compared to previously known fibrin-binding peptides are provided. These fibrin-binding peptides may be conjugated to a detectable label or a therapeutic agent and used to detect and facilitate treatment of pathological conditions associated with the presence of fibrin such as thrombic, angiogenic and neoplastic conditions. These peptides may be used in imaging processes such as MRI, ultrasound and nuclear medicine imaging (e.g. PET, scintigraphic imaging., etc.). The peptides may also be used therapeutically. The present invention also provides processes and methods for making and using such peptides and conjugates thereof.

The invention discloses natural moisturizing skin cream for the purpose of solving the problems that traditional skin cream is poor in moisturizing performance, strong in irritation, large in viscosity and short in oil-control time. According to the technical scheme, the natural moisturizing skin cream is prepared from, by mass, 29-34 parts of caprylic/capric triglyceride, 1-5 parts of C10-18 fatty acid triglyceride, 0.7-3.8 parts of natural emulsifying agent, 0.3-2 parts of sucrose laurate, 0.1-1.2 parts of ceramide, 1-5 parts of squalane, 0.1-0.6 part of cholesterol and 0.3-2.2 parts of C10-30 acid cholesterol/lanosterol mixed ester. The natural moisturizing skin cream is free of irritation, high in moisturizing performance, small in viscosity and long in oil-control time.